How to add baskets to an ongoing basket trial with information borrowing.

Libby Daniells, Pavel Mozgunov, Helen Barnett, Alun Bedding, Thomas Jaki
Author Information
  1. Libby Daniells: STOR-i Centre for Doctoral Training, Department of Mathematics and Statistics, Lancaster University, Lancaster, UK. ORCID
  2. Pavel Mozgunov: MRC Biostatistics Unit, University of Cambridge, Cambridge, UK. ORCID
  3. Helen Barnett: School of Mathematical Sciences, Lancaster University, Lancaster, UK.
  4. Alun Bedding: Roche Products Ltd, Welwyn Garden City, UK.
  5. Thomas Jaki: MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.

Abstract

Basket trials test a single therapeutic treatment on several patient populations under one master protocol. A desirable adaptive design feature is the ability to incorporate new baskets to an ongoing trial. Limited basket sample sizes can result in reduced power and precision of treatment effect estimates, which could be amplified in added baskets due to the shorter recruitment time. While various Bayesian information borrowing techniques have been introduced to tackle the issue of small sample sizes, the impact of including new baskets into the borrowing model has yet to be investigated. We explore approaches for adding baskets to an ongoing trial under information borrowing. Basket trials have pre-defined efficacy criteria to determine whether the treatment is effective for patients in each basket. The efficacy criteria are often calibrated a-priori in order to control the basket-wise type I error rate to a nominal level. Traditionally, this is done under a null scenario in which the treatment is ineffective in all baskets, however, we show that calibrating under this scenario alone will not guarantee error control under alternative scenarios. We propose a novel calibration approach that is more robust to false decision making. Simulation studies are conducted to assess the performance of the approaches for adding a basket, which is monitored through type I error rate control and power. The results display a substantial improvement in power for a new basket, however, this comes with potential inflation of error rates. We show that this can be reduced under the proposed calibration procedure.

Keywords

References

EGEMS (Wash DC). 2013 Jan 17;1(1):1004 [PMID: 25848556]
Control Clin Trials. 1989 Mar;10(1):1-10 [PMID: 2702835]
Contemp Clin Trials. 2022 May;116:106741 [PMID: 35358718]
Pharm Stat. 2023 May-Jun;22(3):531-546 [PMID: 36625301]
Clin Trials. 2009 Jun;6(3):227-38 [PMID: 19528132]
Stat Med. 2023 Oct 30;42(24):4392-4417 [PMID: 37614070]
Biostatistics. 2022 Jan 13;23(1):120-135 [PMID: 32380518]
N Engl J Med. 2015 Aug 20;373(8):726-36 [PMID: 26287849]
J R Stat Soc Ser C Appl Stat. 2022 Nov;71(5):2014-2037 [PMID: 36636028]
Stat Med. 2018 Nov 10;37(25):3557-3572 [PMID: 29984488]
Biostatistics. 2021 Jan 28;22(1):19-34 [PMID: 31107534]
Stat Med. 2011 Jul 30;30(17):2081-9 [PMID: 21413054]
Annu Rev Med. 2018 Jan 29;69:319-331 [PMID: 29120700]
Pharm Stat. 2016 Mar-Apr;15(2):123-34 [PMID: 26685103]
Stat Med. 2020 Nov 10;39(25):3459-3475 [PMID: 32717103]
Cancer. 2024 Jan;130(2):186-200 [PMID: 37934000]
Ann Oncol. 2017 Jan 1;28(1):34-43 [PMID: 28177494]
Clin Trials. 2013 Oct;10(5):720-34 [PMID: 23983156]
PLoS One. 2022 Aug 2;17(8):e0272367 [PMID: 35917296]
Clin Trials. 2018 Apr;15(2):149-158 [PMID: 29499621]
Biom J. 2020 Mar;62(2):361-374 [PMID: 31265159]

MeSH Term

Humans
Bayes Theorem
Sample Size
Clinical Trials as Topic
Research Design
Models, Statistical
Computer Simulation

Word Cloud

Similar Articles

Cited By